CRST
Crest Nicholson Holdings plc is a housebuilding company based in the United Kingdom that focuses on the development of residential properties. The company aims to deliver high-quality homes in desirab...
Deep Value Chronicles on Crest Nicholson Holdings plc (CRST)
主要经营地:英国
详细生意模式:英国住宅建筑商,运营七个房建部门(Southwest, South, Chiltern, Midlands, Eastern, Yorkshire),主要销售open market和bulk/affordable housing;通过land acquisition、开发和销售新建住宅盈利;竞争格局:英国housebuilder众多,面临Barratt、Persimmon等mega-builders和regional players竞争;市场受利率、房价和政府housing policy影响。
护城河:🟡中:(1)Cyclical recovery signal—早期2026 sales rate 0.64 homes/site/week vs FY25平均0.61,虽然小幅改善但momentum向上;(2)Project Elevate transformation—land bank优化、divisional restructuring完成、shift to mid-premium model有执行进展;(3)Government supply dynamics—新房supply constraint supportive,但需求端依赖macro normalization;(4)融资能力—财务状况允许land acquisition,但对利率敏感;(5)政府政策风险—housing policy changes可能影响affordable housing mix和profitability。可持续性:取决于UK housing market recovery速度和Project Elevate执行成功。
估值水平:PE未提供, P/TB 0.38x(严重折价)
EV/Market Cap:EV $314M / MC $267M
网络观点:销售rate改善至0.64(10周到3.20) vs FY25的0.61,反映early 2026 momentum稳定虽然macro risks cautious;Project Elevate progressing:land bank优化、divisional restructuring完成、转向mid-premium model;FY guidance unchanged;0.38x P/TB表示深度折价。
AI观点:CRST是典型的英国housebuilder cyclical turnaround play。WebSearch确认:(1)早期2026 sales rate 0.64确实是positive signal,但相比housebuilder industry需求,仍未恢复到pre-2022水平;(2)Project Elevate战略(mid-premium model shift)是management对市场需求的判断,需validate通过FY26财报;(3)0.38x P/TB极度折价,反映市场对英国housing sector的悲观预期,但也意味着margin of safety较大。关键分析:(1)Housebuilder profitability依赖于新房供应紧张性和需求恢复,两者当前处于不确定阶段;(2)Project Elevate if executed well可以improve margin quality(mid-premium vs lower price point),但execution risk存在;(3)利率环境对end-buyer mortgage availability的影响仍未fully resolved,2026年英国利率走势关键;(4)0.38x P/TB 如果NAV hold,则20-30%上行空间realistic,但需macro tailwind。投资风险:(1)如果英国macro恶化或利率再涨,需求可能重新下行;(2)Project Elevate transition期间可能经历margin pressure;(3)land carrying costs和impairment risks if demand disappointment occurs。建议:Turnaround play with cyclical upside。当前0.38x P/TB估值安全边际大,但需等待FY26 full year results验证sales rate是否能sustain并Project Elevate是否能改善margins。不宜急进入,应观察H1 2026成绩后再决定。